Stock Surge Today: Social media chatter intensified around electroCore as shares climbed over 26 percent to surpass $8 amid strong trading volume.
Revenue and Growth Focus: Observers highlighted the company's first-quarter results showing a 43 percent year-over-year revenue increase to $9.6 million alongside robust 87 percent gross margins and expanding prescriptions through the Department of Veterans Affairs.
Clinical Trial Momentum: Recent publication of positive fibromyalgia data in a major medical journal drew attention for validating the technology's long-term efficacy and positioning the firm for broader adoption.
Note: This discussion summary was generated from an AI condensation of post data.
electroCore Insider Trading Activity
electroCore insiders have traded $ECOR stock on the open market 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ECOR stock by insiders over the last 6 months:
- DANIEL S GOLDBERGER has made 1 purchase buying 1,000 shares for an estimated $4,840 and 1 sale selling 16,072 shares for an estimated $96,753.
- THOMAS J. ERRICO purchased 9,992 shares for an estimated $59,852
- JOSHUA S. LEV (CFO and Interim President) has made 0 purchases and 2 sales selling 5,500 shares for an estimated $32,125.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
electroCore Revenue
electroCore had revenues of $9.6M in Q1 2026. This is an increase of 42.64% from the same period in the prior year.
You can track ECOR financials on Quiver Quantitative's ECOR stock page.
You can access data on ECOR stock through the Quiver Quantitative API.
electroCore Hedge Fund Activity
We have seen 12 institutional investors add shares of electroCore stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. added 116,463 shares (+inf%) to their portfolio in Q1 2026, for an estimated $702,271
- TEJARA CAPITAL LTD added 100,378 shares (+inf%) to their portfolio in Q4 2025, for an estimated $450,195
- DRW SECURITIES, LLC removed 58,768 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $354,371
- INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC removed 42,100 shares (-47.5%) from their portfolio in Q1 2026, for an estimated $253,863
- CITADEL ADVISORS LLC removed 34,644 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $208,903
- WEALTHSHIELD PARTNERS, LLC added 25,978 shares (+inf%) to their portfolio in Q1 2026, for an estimated $156,647
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 19,188 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $115,703
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
